Hospira, Inc. (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies, issued this press release today to further inform the general public about a previously communicated user level recall of a total of 19 lots of carboplatin, cytarabine, paclitaxel, and methotrexate (see table below) in the United States due to visible particles embedded in the glass located at the neck of the vial. There may be potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.